From concept to registered product.
Our R&D capability covers oral solid dosage forms, liquids, semi-solids, powders, capsules, creams, gels, serums and selected medical device categories.
Jardin Probiotic Research Centre (JPRC) extends this with specialised microbiome and probiotic formulation work — supporting next-generation gut, immune and women’s health products.
Whether you bring us a finished formulation, a target molecule, or a market concept, our team will assess feasibility and propose a development pathway including regulatory route.
Formulation development
Oral solids, liquids, semi-solids, capsules, powders, creams, serums — from spec to lab-scale prototype to scale-up.
Probiotic & microbiome R&D
Specialised research at JPRC covering strain characterisation, formulation stability, and clinical-grade probiotic delivery.
Regulatory registration
MAL (pharmaceutical), MDA (medical device) and NOT (cosmetic) submission and lifecycle management with NPRA, MOH and MDA.
How we move from idea to market.
Feasibility assessment
Initial scoping covering regulatory pathway, formulation technical feasibility, and indicative cost.
Lab-scale development
Formulation work, stability testing, analytical method validation.
Pilot & scale-up
Pilot batches at JMSB or TLP, process validation, packaging trials.
Registration & launch
Dossier compilation, NPRA / MDA / MOH submission, commercial production.
Brief us on your concept.
Free 30-minute scoping call — we assess feasibility, regulatory route and indicative timeline within two working days.
Submit R&D enquiryJPRC — our specialised research centre.
Microbiome and probiotic science under the Jardin Pharma group, supporting next-generation product development.
About JPRC